These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25104263)

  • 1. Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial.
    Beksinska ME; Piaggio G; Smit JA; Wu J; Zhang Y; Pienaar J; Greener R; Zhou Y; Joanis C
    Lancet Glob Health; 2013 Sep; 1(3):e146-52. PubMed ID: 25104263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2.
    Beksinska M; Greener R; Kleinschmidt I; Pillay L; Maphumulo V; Smit J
    Contraception; 2015 Sep; 92(3):261-7. PubMed ID: 26002805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.
    Beksinska M; Smit J; Mabude Z; Vijayakumar G; Joanis C
    Contraception; 2006 Apr; 73(4):386-93. PubMed ID: 16531173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional performance study of an adapted design of the woman's condom: a crossover, noninferiority, randomized clinical trial.
    Beksinska M; Greener R; Mphili N; Smit J; Kilbourne-Brook M; Coffey PS
    Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):233-239. PubMed ID: 31112062
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative crossover study of the PATH Woman's Condom and the FC Female Condom.
    Schwartz JL; Barnhart K; Creinin MD; Poindexter A; Wheeless A; Kilbourne-Brook M; Mauck CK; Weiner DH; Callahan MM
    Contraception; 2008 Dec; 78(6):465-73. PubMed ID: 19014792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice makes perfect: reduction in female condom failures and user problems with short-term experience in a randomized trial.
    Beksinska M; Smit J; Joanis C; Hart C
    Contraception; 2012 Aug; 86(2):127-31. PubMed ID: 22264667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.
    Smit J; Beksinska M; Vijayakumar G; Mabude Z
    Contraception; 2006 Apr; 73(4):394-8. PubMed ID: 16531174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of female condoms and failures reported with two different types in China.
    Wang X; Xi M; Zhang L; Jia L; Wang Y; Cheng Y
    Int J Gynaecol Obstet; 2015 Feb; 128(2):152-6. PubMed ID: 25458411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The female condom learning curve: patterns of female condom failure over 20 uses.
    Beksinska M; Smit J; Greener R; Piaggio G; Joanis C
    Contraception; 2015 Jan; 91(1):85-90. PubMed ID: 25444717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the woman's condom among couples in Shanghai, China.
    Zirong H; Junqing W; Coffey PS; Kilbourne-Brook M; Yufeng Z; Wang C; Hongxin Z; Bin W; Yuyan L; Hongbo P
    Eur J Contracept Reprod Health Care; 2012 Jun; 17(3):212-8. PubMed ID: 22497293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and performance of the menstrual cup in South Africa: a randomized crossover trial comparing the menstrual cup to tampons or sanitary pads.
    Beksinska ME; Smit J; Greener R; Todd CS; Lee ML; Maphumulo V; Hoffmann V
    J Womens Health (Larchmt); 2015 Feb; 24(2):151-8. PubMed ID: 25682816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial reactions to the Woman's Condom by potential user groups in Shanghai, China.
    Coffey PS; Kilbourne-Brook M; Junqing W; Yufeng Z; Hongxin Z; Bin W; Na L; Rui Z; Yuyan L
    J Fam Plann Reprod Health Care; 2013 Apr; 39(2):111-20. PubMed ID: 22906855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional performance of the Wondaleaf condom: A crossover, noninferiority, randomized clinical trial.
    Beksinska M; Mphili N; Smit J
    Int J STD AIDS; 2023 Feb; 34(2):114-121. PubMed ID: 36426764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis.
    Wiyeh AB; Mome RKB; Mahasha PW; Kongnyuy EJ; Wiysonge CS
    BMC Public Health; 2020 Mar; 20(1):319. PubMed ID: 32164652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of Phoenurse female condom and second-generation Femidom female condom in Chinese women.
    Wang X; Liu M; Cheng Y
    J Obstet Gynaecol Res; 2016 Nov; 42(11):1567-1574. PubMed ID: 27444262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.
    ; Carey D; Puls R; Amin J; Losso M; Phanupak P; Foulkes S; Mohapi L; Crabtree-Ramirez B; Jessen H; Kumar S; Winston A; Lee MP; Belloso W; Cooper DA; Emery S
    Lancet Infect Dis; 2015 Jul; 15(7):793-802. PubMed ID: 25877963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary comparison of the polyurethane female condom with the latex male condom in Kenya.
    Ruminjo JK; Steiner M; Joanis C; Mwathe EG; Thagana N
    East Afr Med J; 1996 Feb; 73(2):101-6. PubMed ID: 8756048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
    Dowdy DW; Sweat MD; Holtgrave DR
    AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of communication strategies to increase knowledge, acceptability, and uptake of a new Woman's Condom in urban Lusaka, Zambia: study protocol for a randomized controlled trial.
    Pinchoff J; Chowdhuri RN; Taruberekera N; Ngo TD
    Trials; 2016 Dec; 17(1):596. PubMed ID: 27964747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term acceptability of the PATH Woman's Condom among couples at three sites.
    Coffey PS; Kilbourne-Brook M; Austin G; Seamans Y; Cohen J
    Contraception; 2006 Jun; 73(6):588-93. PubMed ID: 16730489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.